Last updated 2026-08-06
- Raised $20M Series C led by OrbiMed, Oct 2020
- Raised $16M Series B led by OrbiMed, Oct 2017
- Raised $1.2M Series A led by Ganot Capital, Mar 2014
Total raised
$37.2M
Stage
—
Founded
2013
Headcount
—
HQ
Tel Aviv, Israel
Sector
Biotechnology
About
Azura Ophthalmics is a clinical-stage biopharmaceutical company focused on developing a new therapeutic class of Ophthalmic Keratolytics to treat underserved ophthalmic conditions. Their approach combines ophthalmologic and dermatologic solutions to address the root cause of various ocular indications, including Meibomian Gland Dysfunction (MGD), Dry Eye Disease (DED), and Contact Lens Discomfort (CLD). The company's lead product candidate, AZR-MD-001, is an investigational ophthalmic keratolytic targeting MGD and is currently in Phase 3 clinical trials.
Funding history · 3 rounds · $37.2M total
2020-10
C Round
$20.0M
★ OrbiMed★ TPG Biotech★ Ganot Capital★ Brandon Capital's Medical Research Commercialization FundBrandon Capital's Medical Research Commercialisation Fund (MRCF)Brandon Capital's Medical Research Commercialization Fund (MRCF)
2017-10
B Round
$16.0M
★ OrbiMed★ TPG Biotech★ Brandon Capital's Medical Research Commercialisation FundGanot CapitalBrandon Capital's Medical Research Commercialisation Fund (MRCF)
2014-03
A Round
$1.2M
★ Ganot CapitalElron Industries
Team · 15
Yair Alster
Founder · Co-founder and Chief Technology Officer
Omer Rafaeli
Founder · Co-founder and Director of Scientific Research
Marc Gleeson
Chief Executive Officer
Charles Bosworth
Chief Medical Officer
Hila Barash
Chief Research and Development Officer
Patty Delaney
Global Head of Project Management
Shimon Nahum
Senior Manager Formulation and CMC
Abby Aharonov
Office Manager
Steven Altschuler
Board Chair
Erez Chimovits
Partner
Chris Nave
Founding Partner and Managing Director, Brandon Capital
Heather Preston
Director, Oxford Biomedica
Guy Katsav
Managing Director, Healthcare Investments, Ganot Capital
Anat Naschitz
Board Member
Ashwin Agarwal
Chief Financial Officer
Sectors & technology
Primary sector
Biotechnology
Technologies
Target customers
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | azuraophthalmics.com |
|---|
Identifiers & details
| Legal name | Azura Ophthalmics |
|---|---|
| Founded | 2013 |
Radar intelligence
Patents
| EPO | 29 |
|---|
Publications (Crossref)
| Works | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515003747 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2013-12-19 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 7 — shares_capital (4), violation (1), annual_report (1), other (1) |
| Registered address | דרויאנוב 5 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-28 | הגדלה של הון רשום |
| 2026-06-22 | עדכון הפרה |
| 2026-06-17 | דו~ח שנתי-הוספת דירקטור |
| 2026-07-09 | העברת מניות |
| 2026-07-07 | שינוי בהרכב הון - מניות-שינוי סוג מניה |
| 2026-07-02 | שינוי בתקנון |
| 2026-07-02 | הקצאת מניות |